Investor · 1 deal
Every published round NorthStar Impact Funds took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Recce Pharmaceuticals | Unnamed stage | 10 Jul 2024 | - | Participant | @AuManufacturing |
Companies NorthStar Impact Funds has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Recce Pharmaceuticals | 10 Jul 2024 | 1 | 0 |
Fund closes reported for NorthStar Impact Funds, as distinct from the investments it has made.
Companies NorthStar Impact Funds has backed that another company then bought. An exit for the holding, not a deal NorthStar Impact Funds did.
Stories naming NorthStar Impact Funds. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup: Orthocell reports higher revenue, Recce Pharmaceuticals raises $8 million via a placement, executive appointments at Blacktree and Memphasys, Crosbe launches low-carbon grouts, NSW forms a Net Zero Commission, QUT unveils mapping research.